Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan C Modesitt

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Obstetrics and Gynecology|August 24, 2013
In replySusan C Modesitt
Gynecologic Oncology Reports|May 9, 2022
EditorialSusan C Modesitt
Obstetrics and Gynecology|October 24, 2012
Missed opportunities for primary endometrial cancer prevention: how to optimize early identification and treatment of high-risk womenSusan C Modesitt
Gynecologic Oncology Reports|July 4, 2025
Silence is not an acceptable response to accusations of corruption: Expertise, integrity, and robust peer review processes safeguard ethical and data driven medical publicationsSusan C Modesitt
Obstetrics and Gynecology|May 3, 2013
What is new in gynecologic oncology?: thought-provoking articles from the past yearSusan C Modesitt
Gynecologic Oncology Reports|July 3, 2023
Gynecologic Oncology Reports: 2022 and beyondSusan C Modesitt
Obstetrics and Gynecology|December 2, 2014
What is new in endometrial hyperplasia treatment or prevention? Best articles from the past yearSusan C Modesitt
Gynecologic Oncology Reports|October 14, 2024
The time is now: Concrete actions are needed to improve diversity and representation in clinical trials participationJhalak Dholakia, Susan C Modesitt
Gynecologic Oncology|August 3, 2010
In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: does timing matter?Susan C Modesitt, Sarah J Parsons
Gynecologic Oncology|July 28, 2006
Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 casesStephanie A Freeman, Susan C Modesitt
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Obstetrics and Gynecology|August 24, 2013
In replySusan C Modesitt
Gynecologic Oncology Reports|May 9, 2022
EditorialSusan C Modesitt
Obstetrics and Gynecology|October 24, 2012
Missed opportunities for primary endometrial cancer prevention: how to optimize early identification and treatment of high-risk womenSusan C Modesitt
Gynecologic Oncology Reports|July 4, 2025
Silence is not an acceptable response to accusations of corruption: Expertise, integrity, and robust peer review processes safeguard ethical and data driven medical publicationsSusan C Modesitt
Obstetrics and Gynecology|May 3, 2013
What is new in gynecologic oncology?: thought-provoking articles from the past yearSusan C Modesitt
Gynecologic Oncology Reports|July 3, 2023
Gynecologic Oncology Reports: 2022 and beyondSusan C Modesitt
Obstetrics and Gynecology|December 2, 2014
What is new in endometrial hyperplasia treatment or prevention? Best articles from the past yearSusan C Modesitt
Gynecologic Oncology Reports|October 14, 2024
The time is now: Concrete actions are needed to improve diversity and representation in clinical trials participationJhalak Dholakia, Susan C Modesitt
Gynecologic Oncology|August 3, 2010
In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: does timing matter?Susan C Modesitt, Sarah J Parsons
Gynecologic Oncology|July 28, 2006
Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 casesStephanie A Freeman, Susan C Modesitt
Pageof 12